Trevi Therapeutics TRVI
NASDAQ TRVI
$12.61 -0.33 (-2.55%)
At close: Oct 23, 2026 · 4:00 PM EDT

Trevi Therapeutics (TRVI) Amortization of Deferred Charges (2018 - 2023)

Updated

Analysis

Trevi Therapeutics (TRVI) Amortization of Deferred Charges (2018 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Trevi Therapeutics 1.98 Bn 1.10 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 99,000.00
Mar 31, 2023 81,000.00
Dec 31, 2022 101,000.00
Sep 30, 2022 122,000.00
Jun 30, 2022 143,000.00
Mar 31, 2022 154,000.00
Dec 31, 2021 157,000.00
Sep 30, 2021 151,000.00
Jun 30, 2021 146,000.00
Mar 31, 2021 145,000.00
Dec 31, 2020 159,000.00
Jun 30, 2018 17,000.00
Mar 31, 2018 43,000.00
API Access

Trevi Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=TRVI&period=max&api_key=YOUR_API_KEY